December 16, 2009 – Patient enrollment was recently completed for a study evaluating the ability of cardiopoietic cells to restore cardiac function in heart failure patients.

December 15, 2009 – CE Mark approval has been granted for Pathway Medical Technologies’ Jetstream G2TM NXT System, a peripheral atherectomy catheter for use in the treatment of PAD.

December 14, 2009 – A new drug application (NDA) was recently submitted to the U.S. Food and Drug Administration (FDA) for ticagrelor, an investigational oral anti-platelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndrome (ACS).

December 14, 2009 – First new anti-arrhythmic drug to be approved in the European Union in the last 10 years was recently granted European Commission marketing authorization.

December 10, 2009 – European approval was recently granted for the use of Angiox (bivalirudin) as an anti-coagulant in patients with ST-segment elevated myocardial infarction (STEMI) who undergoing emergency primary percutaneous coronary intervention (PCI).

December 9, 2009 — A new cardiovascular care system was previewed during the recent Medica exhibition in Germany. The system, slated for a 2010 launch, provides clinical decision support for cardiovascular care of critically ill patients.

December 9, 2009 - An expert panel reviewing Canadian medical isotope productions selected electron beam technology as a superior approach to accelerator-based isotope production. The panel has recommended the Canadian government make an investment in linear accelerator (linac) technology to address the country’s shrinking isotope supply.